Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Breast Cancer Risk Reduction
NCT02028221Phase 2Completed
- Sponsor
- University of Arizona
- Start
- Mar 2014
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in breast cancer, sponsored by University of Arizona. Started Mar 2014; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02028221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02028221.